Hair Loss Therapy With Results
Dr. Sekhavat has considerable experience in various fields of research. He is the founder and principal investigator of Triple Hair. Listen to what he has to say about the results of the first clinical trials of Triple Hair’s regrowth products.
Androgenetic alopecia is hair loss (at scalp level) caused by the thinning of hair follicles. It is very common in men between the ages of 19 and 65.
Triple Hair has conducted a proof of concept for the effectiveness in stopping hair loss and augmenting hair thickness, pigmentation and number of hair follicles.
In the clinical trials, 52% of patients have experienced dense regrowth with TH07 Prescription Product and 50% with the Natural Product TH16.
Experience Dense Regrowth
Recent Results From Our Clinical Trials
The following BEFORE and AFTER images highlight the results and effectiveness of Triple Hair TH07 over a six month duration.
The participants had obtained positive results during this clinical Study. All participants had hair regrowth. For the majority, regrowth was outstanding and for others the results were moderate.